Mustang Bio, Inc. (MBIO) earnings
MBIO earnings moved a median of +0.89% by the close. Quarterly and annual MBIO reports and results, each read against the price at its own news timestamp. Back to the MBIO overview →
13 measured MBIO earnings events.
Where these MBIO earnings landedvs 13 measured MBIO earnings reactions
| Middle 50% of MBIO earnings reactions | -0.44% to +2.24% |
|---|---|
| Median reaction (to close) | +0.89% |
| Measured reactions | 13 |
Point-in-time · zero look-ahead
Half of the 13 MBIO earnings events with a measured close landed between -0.44% and +2.24%; 62% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q MUSTANG BIO, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +8.45% | |
| Form 10-Q MUSTANG BIO, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.03% | -0.44% | |
| Form 10-K MUSTANG BIO, INC. For: Dec 31 | SEC filing · Form 10-K | -2.44% | +2.24% | |
| Form 10-Q MUSTANG BIO, INC. For: Sep 30 | SEC filing · Form 10-Q | -0.75% | -7.52% | |
| Form 10-Q MUSTANG BIO, INC. For: Jun 30 | SEC filing · Form 10-Q | +1.09% | +10.69% | |
| Form 10-Q MUSTANG BIO, INC. For: Mar 31 | SEC filing · Form 10-Q | -0.54% | +0.89% | |
| Form 10-K MUSTANG BIO, INC. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -5.67% | |
| Form 10-Q MUSTANG BIO, INC. For: Sep 30 | SEC filing · Form 10-Q | +1.96% | +0.78% | |
| Form 10-Q MUSTANG BIO, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.30% | +0.00% | |
| Form 10-Q MUSTANG BIO, INC. For: Mar 31 | SEC filing · Form 10-Q | -1.32% | +12.82% | |
| Form 10-K MUSTANG BIO, INC. For: Dec 31 | SEC filing · Form 10-K | +3.51% | -7.02% | |
| Form 10-Q MUSTANG BIO, INC. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +1.27% | |
| Mustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights | Press release | +0.00% | +1.27% |
Keep exploring
More MBIO: analyst actions → · SEC filings → · MBIO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Oramed Pharmaceuticals Inc. (ORMP) | 145 | +0.69% | 69% |
| GlycoMimetics, Inc. (GLYC) | 144 | +0.53% | 54% |
| Patterson Companies, Inc. (PDCO) | 144 | 0.00% | 48% |
| Propanc Biopharma, Inc. (PPCB) | 144 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.